- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.02. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference | 314 | ACCESS Newswire | Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as... ► Artikel lesen | |
| 22.01. | Filament Health Corp: Filament Health ships PEX010 to UW-Madison | 1 | Stockwatch | ||
| 21.01. | Filament Health Announces Shipment Of Botanical Psilocybin To The University Of Wisconsin-madison | 1 | CNW | ||
| FILAMENT HEALTH Aktie jetzt für 0€ handeln | |||||
| 07.01. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum | 371 | ACCESS Newswire | Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications... ► Artikel lesen | |
| 16.12.24 | Filament Health Corp: Filament Health JV Magdalena imports six kg coca leaf | 2 | Stockwatch | ||
| 16.12.24 | Filament Health Announces Import Of Coca Leaf From Peru By Joint Venture Magdalena Biosciences | 3 | CNW | ||
| 15.11.24 | Filament Health reports Q3 results | 5 | Seeking Alpha | ||
| 15.11.24 | Filament Health Announces Third Quarter 2024 Financial Results And Operational Highlights | 6 | CNW | ||
| 10.10.24 | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum | 515 | ACCESS Newswire | Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications... ► Artikel lesen | |
| 04.10.24 | Filament Health Corp: Filament issues 5.6 million shares under advisory deal | 1 | Stockwatch | ||
| 04.10.24 | Filament Health Announces Issuance Of Common Shares To Negev Capital Investments Limited Pursuant To Advisory Agreement | 1 | CNW | ||
| 15.06.24 | Negev Capital Fund One, L.P. Reports Updated Holdings in Filament Health Corp. | 625 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - Negev Capital Fund One, L.P. (the "Acquiror"), a shareholder of Filament Health Corp. ("Filament"), announces that on June 12, 2024,... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 24,000 | +5,68 % | UBS stuft BAYER AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Bayer auf "Neutral" mit einem Kursziel von 22 Euro belassen. Er rechne mit einem eher positiven Ausblick von Bayer auf das... ► Artikel lesen | |
| AURORA CANNABIS | 4,560 | -0,96 % | UNGLAUBLICHE Sondermeldung bei Aurora Cannabis Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
| CANOPY GROWTH | 1,190 | +0,85 % | UNGLAUBLICHE Sondermeldung bei Canopy Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
| TILRAY BRANDS | 0,650 | -0,46 % | UNGLAUBLICHE Sondermeldung bei Tilray Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
| INNOCAN PHARMA | 0,130 | -0,38 % | InnoCan Pharma: Großaktionär erhöht den Bestand auf über 20%?! | ||
| CRONOS GROUP | 1,853 | -1,65 % | Cronos Group Inc.: Cronos Group Reports 2024 Fourth Quarter and Full-Year Results | Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 million Spinach® Ends 2024 as the Number One Cannabis Brand... ► Artikel lesen | |
| SYNBIOTIC | 3,560 | -2,73 % | SYNBIOTIC plant weitere Übernahmen in 2025 | Mitteilung der SYNBIOTIC SE: SYNBIOTIC mit vier neuen Beteiligungen in 2024: Weitere Übernahmen für 2025 in Sicht Die europäische Industriehanf- und Cannabis-Unternehmensgruppe SYNBIOTIC SE (ISIN DE000A3E5A59... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,550 | -1,65 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2024 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,019 | -5,00 % | Christina Lake Cannabis Corp.: Christina Lake Cannabis Provides Business Update | VANCOUVER, British Columbia, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the "Company" or "CLC" or "Christina Lake Cannabis") (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased... ► Artikel lesen | |
| AXSOME THERAPEUTICS | 123,75 | +2,02 % | Axsome Therapeutics gets FDA support to submit sNDA for its Alzheimer's disease agitation treatment | ||
| JAGUAR HEALTH | 0,570 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value | Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion diseaseFDA... ► Artikel lesen | |
| JAZZ PHARMACEUTICALS | 133,65 | -0,07 % | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance | - Record total revenues of $4.1 billion in 2024 and $1.1 billion in 4Q24 -- Xywav® and Epidiolex® revenues grew 16% and 15% year-over-year, respectively, in 2024 -- Oncology revenues grew... ► Artikel lesen | |
| TRULIEVE CANNABIS | 3,992 | -1,24 % | Trulieve Cannabis Corp.: Trulieve Reports Fourth Quarter and Full Year 2024 Results Highlighting Margins and Cash Flow | Fourth quarter revenue of $301 million, up 5% year over year, exceeding guidance
Gross margin of 62%, compared to 54% during the fourth quarter of 2023
... ► Artikel lesen | |
| JUVA LIFE | 0,023 | -100,00 % | Juva Life Aktie: Zinspolitik belastet Ausblick | Die Juva Life Inc. zeigt zum Stichtag 18. Januar 2025 eine bemerkenswerte Stagnation im Handel. Der Aktienkurs verharrt bei 0,0000 USD, was die anhaltenden Herausforderungen des Cannabisunternehmens... ► Artikel lesen | |
| CORBUS PHARMACEUTICALS | 6,900 | +3,76 % | William Blair starts Corbus stock with Outperform rating |
FILAMENT HEALTH CORP gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,004 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FILAMENT HEALTH CORP finden Sie auf Wallstreet Online.
